60 results
424B3
DMAC
DiaMedica Therapeutics Inc.
18 Jul 24
Prospectus supplement
5:28pm
ReMEDy2 trial and any other clinical trials we conduct;
our commercialization, marketing and manufacturing capabilities and strategy;
expectations
8-K
EX-10.1
b8juygyvlmt5
5 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
fr6j3zpwo jn7
5 Sep 23
Departure of Directors or Certain Officers
4:15pm
424B3
fsxx1y
10 Jul 23
Prospectus supplement
4:16pm
8-K
EX-99.1
05x2quuxt
30 May 23
DiaMedica Therapeutics Announces Appointment of Dr. Richard Kuntz to the Board of Directors
8:30am
8-K
EX-10.2
jrvuddx uz4
25 May 22
Departure of Directors or Certain Officers
4:49pm